Nordic Life Science 1
Business deals – Acquisitions – Agreements – Coll
aborations T E X T BY M AL IN O T M ANI Magnus Björsne, CEO, BioVentureHub MED T E C H Getinge inaugurates its Global Centre of Excellence for Chemistry The new center, which also becomes the UK headquarters, brings together the company’s chemistry and instrument decontamination business Ketil Widerberg, General Manager, Oslo Cancer Cluster J O IN IN G F OR C E S A new Swedish-Norwegian health industry collaboration An agreement between AstraZeneca, Oslo Cancer Cluster, and Oslo Science City aims to strengthen the Nordic health industry by facilitating closer collaboration between researchers, startups, and pharma companies. THE AGREEMENT WILL facilitate Norwegian startups’ access to residency at AstraZeneca’s innovation hub, BioVentureHub, in Gothenburg. Simultaneously, Swedish companies will have the opportunity to reside at Oslo Cancer Cluster (OCC) and collaborate closely with their environments in cancer and precision medicine, as well as the research groups from the Radium Hospital. OCC will have the role of identifying the companies that are offered residency in BioVentureHub. “BioVentureHub can connect our startups to international value chains, and it is only a short train ride from Oslo. I think that will be quite effective!” says Ketil Widerberg, General manager, OCC. The parties to the agreement also want to involve Innovation Norway, whereby Norwegian companies staying at BioVentureHub can apply for support during their residency. In the long term, the goal is also to involve Vinnova, Innovation Norway’s Swedish sister organization, in the collaboration. NLS GETINGE IS THE first medtech company to move into the growing industrial and logistics park, St. Modwen Park in Derby, and during the opening Getinge showcased the 79,000 sq/ft production, warehouse, laboratory, showroom, training area and office space. With the new facilities, Getinge is bringing together its chemistry and instrument decontamination business, as well as its UK sales offices, service functions and logistics operations. “A new era for our teams, where for the first time in our UK Getinge history all employees can come together under ‘one roof´ is an incredible feeling,” stated Avril Forde, President North Europe Region, Getinge. NLS SEK 1.67 MILLION … … is the worth of the new 2-year license agreement that Qlucore has signed with Boehringer Ingelheim. Getinge's new Global Centre of Excellence for Chemistry NORDICLIFESCIENCE.ORG | 11 PHOTO GORM K GAARE PHOTO DANIEL FORSSBERG